Combination of Two Immunotherapies Brings Advanced Melanoma Survival Rate to 50% for First Time

By combining two existing therapies, researchers at the Royal Marsden NHS Foundation Trust in London have found that they have been able to stop or even …


Leave a Reply

Your email address will not be published. Required fields are marked *